slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8.790 KRW | +0,11% | -1,68% | +58,09% |
Vakgebied
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 183 | 100,0 % | 334 | 100,0 % | +82,12% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
100,0
%
| 159 | 86,7 % | 334 | 100,0 % | +109,99% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sang-Hyeon Lee
CEO | Chief Executive Officer | 51 | - |
Hwa-Sub Choi
DFI | Director of Finance/CFO | 50 | - |
Joon-Kwon Park
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
Jae-Seung Sim
AUD | Comptroller/Controller/Auditor | 65 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sang-Hyeon Lee
CEO | Chief Executive Officer | 51 | - |
Joon-Kwon Park
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
Wan-Gyun Jung
BRD | Director/Board Member | 65 | - |
Hwa-Sub Choi
DFI | Director of Finance/CFO | 50 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 8 401 272 | 3 329 282 ( 39,63 %) | 85 ( 0,001012 %) | 39,63 % |
Bedrijfsgegevens
Femtobiomed, Inc.
Unit301, Pangyo Seven Valley 2 17, Pangyo-ro 228beon-gil
13487, Seongnam-si
+
http://www.femtobiomed.comSector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+58,09% | 52,69 mln. | |
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |
- Beurs
- Aandelen
- Koers A327610
- Onderneming Femtobiomed Inc.